The Hypodermic Needles Market by Product, End-user, and Geography – Forecast and Analysis 2023-2027 report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 7.43% and register an incremental growth of USD 1,913.12 million during the forecast period. The report includes historic market data from 2017 to 2021. In 2017, the hypodermic needles market was valued at USD 3,646.81 million. The report also provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download a PDF sample report
Company profiles
The hypodermic needles market report includes information on the key products and recent developments of leading vendors, including:
- B. Braun SE: The company offers pro category hypodermic needles that are used for standard injection in clinical settings.
- Becton Dickinson and Co.: The company offers microlance hypodermic needles.
- Cadence Inc.: The company offers industrial filling needles that are designed to dispense precise measure of liquids or gas into bladder, capsules, cartridges, and other vessels.
- Cardinal Health Inc.: The company offers soft pack hypodermic needles with polypropylene hub.
- Connecticut Hypodermics Inc.: The company offers hypodermic needles made up of stainless steel.
- DeRoyal Industries Inc.
- EXELINT International Co.
- Hamilton Bonaduz AG
- Hindustan Syringes and Medical Devices Ltd.
- To gain access to more vendor profiles available with Technavio, buy the report!
Regional analysis
Based on region, the global hypodermic needles market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America is estimated to account for 39% of the growth of the global market during the forecast period. The US is a key contributor to the market owing to widespread insurance coverage, increasing R&D expenditure, growing aging population with chronic diseases, increasing needlestick injuries (NSIs), demand for self-administered drugs, increasing awareness about safe injectable technology, and high healthcare spending.
Market dynamics
The market is driven by factors such as the increasing target population requiring hypodermic needles, rising compliance of safety needles, and market expansion in emerging economies. However, the high cost of safety needles is hindering the market growth.
Competitive analysis
The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share, among others. Request a sample
Market segmentation
- Based on product, the market is segmented into safety needles and non-safety needles. The safety needlessegment accounted for the largest share of the market in 2022.
- Based on geography, the market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America accounted for the largest share of the market in 2022.
- Based on end-user, the market is segmented into hospitals and clinics, ASCs, and others.
Related Reports:
The syringe and needle market size is expected to grow by USD 7.83 billion and CAGR of 7.42% during the forecast period 2021 to 2026. The increasing prevalence of critical care conditions is one of the key drivers supporting the syringe and market share growth, although factors such as Competition from alternative drug delivery systems may impede the market growth.
The surgical sutures market is estimated to grow at a CAGR of 4.68% between 2022 and 2027. The size of the market is forecasted to increase by USD 1,102.57 million. The increase in the number of surgeries is notably driving the market growth, although factors such as the growing preference for MIS may impede the market growth.
Technavio’s library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our “Basic Plan” at just USD 5,000 and get lifetime access to Technavio Insights
What are the key data covered in this hypodermic needles market report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the hypodermic needles market between 2023 and 2027
- Precise estimation of the size of the hypodermic needles market and its contribution to the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of hypodermic needles market vendors
| Hypodermic Needles Market Scope | |
| Report Coverage | Details |
| Page number | 160 |
| Base year | 2022 |
| Historic period | 2017-2021 |
| Forecast period | 2023-2027 |
| Growth momentum & CAGR | Accelerate at a CAGR of 7.43% |
| Market growth 2023-2027 | USD 1,913.12 million |
| Market structure | Fragmented |
| YoY growth 2022-2023(%) | 6.65 |
| Regional analysis | North America, Europe, Asia, and Rest of World (ROW) |
| Performing market contribution | North America at 39% |
| Key countries | US, UK, Germany, Japan, and China |
| Competitive landscape | Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
| Key companies profiled | B. Braun SE, Becton Dickinson and Co., Cadence Inc., Cardinal Health Inc., Connecticut Hypodermics Inc., DeRoyal Industries Inc., EXELINT International Co., Hamilton Bonaduz AG, Hindustan Syringes and Medical Devices Ltd., Hi Tech Medics Pvt Ltd., Iscon Surgicals Ltd., Medline Industries LP, Medtronic Plc, Nipro Medical Corp., Novo Nordisk AS, Retractable Technologies Inc., Smiths Group Plc, Terumo Medical Corp., Vita Needle Co., and Vygon SAS |
| Market dynamics | Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period. |
| Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Browse for Technavio’s health care market reports
Table of contents:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global hypodermic needles market 2017 – 2021
- Exhibit 18: Historic Market Size – Data Table on Global hypodermic needles market 2017 – 2021 ($ million)
- 4.2 Product Segment Analysis 2017 – 2021
- Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
- 4.3 End user Segment Analysis 2017 – 2021
- Exhibit 20: Historic Market Size – End user Segment 2017 – 2021 ($ million)
- 4.4 Geography Segment Analysis 2017 – 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
- 4.5 Country Segment Analysis 2017 – 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by Product
- 6.1 Market segments
- Exhibit 30: Chart on Product – Market share 2022-2027 (%)
- Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
- 6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product
- 6.3 Safety needles – Market size and forecast 2022-2027
- Exhibit 34: Chart on Safety needles – Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Safety needles – Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Safety needles – Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Safety needles – Year-over-year growth 2022-2027 (%)
- 6.4 Non-safety needles – Market size and forecast 2022-2027
- Exhibit 38: Chart on Non-safety needles – Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Non-safety needles – Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Non-safety needles – Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Non-safety needles – Year-over-year growth 2022-2027 (%)
- 6.5 Market opportunity by Product
- Exhibit 42: Market opportunity by Product ($ million)
7 Market Segmentation by End-user
- 7.1 Market segments
- Exhibit 43: Chart on End-user – Market share 2022-2027 (%)
- Exhibit 44: Data Table on End-user – Market share 2022-2027 (%)
- 7.2 Comparison by End-user
- Exhibit 45: Chart on Comparison by End-user
- Exhibit 46: Data Table on Comparison by End-user
- 7.3 Hospitals and clinics – Market size and forecast 2022-2027
- Exhibit 47: Chart on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
- Exhibit 48: Data Table on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Chart on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
- Exhibit 50: Data Table on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
- 7.4 ASCs – Market size and forecast 2022-2027
- Exhibit 51: Chart on ASCs – Market size and forecast 2022-2027 ($ million)
- Exhibit 52: Data Table on ASCs – Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Chart on ASCs – Year-over-year growth 2022-2027 (%)
- Exhibit 54: Data Table on ASCs – Year-over-year growth 2022-2027 (%)
- 7.5 Others – Market size and forecast 2022-2027
- Exhibit 55: Chart on Others – Market size and forecast 2022-2027 ($ million)
- Exhibit 56: Data Table on Others – Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Chart on Others – Year-over-year growth 2022-2027 (%)
- Exhibit 58: Data Table on Others – Year-over-year growth 2022-2027 (%)
- 7.6 Market opportunity by End-user
- Exhibit 59: Market opportunity by End-user ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 61: Chart on Market share by geography 2022-2027 (%)
- Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 63: Chart on Geographic comparison
- Exhibit 64: Data Table on Geographic comparison
- 9.3 North America – Market size and forecast 2022-2027
- Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
- Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
- Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
- Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
- 9.4 Europe – Market size and forecast 2022-2027
- Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
- Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
- Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
- Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
- 9.5 Asia – Market size and forecast 2022-2027
- Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
- Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
- Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
- Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
- Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
- Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
- Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
- Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
- 9.7 US – Market size and forecast 2022-2027
- Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
- Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
- Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
- Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
- 9.8 UK – Market size and forecast 2022-2027
- Exhibit 85: Chart on UK – Market size and forecast 2022-2027 ($ million)
- Exhibit 86: Data Table on UK – Market size and forecast 2022-2027 ($ million)
- Exhibit 87: Chart on UK – Year-over-year growth 2022-2027 (%)
- Exhibit 88: Data Table on UK – Year-over-year growth 2022-2027 (%)
- 9.9 Japan – Market size and forecast 2022-2027
- Exhibit 89: Chart on Japan – Market size and forecast 2022-2027 ($ million)
- Exhibit 90: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
- Exhibit 91: Chart on Japan – Year-over-year growth 2022-2027 (%)
- Exhibit 92: Data Table on Japan – Year-over-year growth 2022-2027 (%)
- 9.10 Germany – Market size and forecast 2022-2027
- Exhibit 93: Chart on Germany – Market size and forecast 2022-2027 ($ million)
- Exhibit 94: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
- Exhibit 95: Chart on Germany – Year-over-year growth 2022-2027 (%)
- Exhibit 96: Data Table on Germany – Year-over-year growth 2022-2027 (%)
- 9.11 China – Market size and forecast 2022-2027
- Exhibit 97: Chart on China – Market size and forecast 2022-2027 ($ million)
- Exhibit 98: Data Table on China – Market size and forecast 2022-2027 ($ million)
- Exhibit 99: Chart on China – Year-over-year growth 2022-2027 (%)
- Exhibit 100: Data Table on China – Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity by geography
- Exhibit 101: Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 102: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 104: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 105: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 106: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 107: Matrix on vendor position and classification
- 12.3 B. Braun SE
- Exhibit 108: B. Braun SE – Overview
- Exhibit 109: B. Braun SE – Business segments
- Exhibit 110: B. Braun SE – Key news
- Exhibit 111: B. Braun SE – Key offerings
- Exhibit 112: B. Braun SE – Segment focus
- 12.4 Becton Dickinson and Co.
- Exhibit 113: Becton Dickinson and Co. – Overview
- Exhibit 114: Becton Dickinson and Co. – Business segments
- Exhibit 115: Becton Dickinson and Co. – Key news
- Exhibit 116: Becton Dickinson and Co. – Key offerings
- Exhibit 117: Becton Dickinson and Co. – Segment focus
- 12.5 Cadence Inc.
- Exhibit 118: Cadence Inc. – Overview
- Exhibit 119: Cadence Inc. – Product / Service
- Exhibit 120: Cadence Inc. – Key offerings
- 12.6 Cardinal Health Inc.
- Exhibit 121: Cardinal Health Inc. – Overview
- Exhibit 122: Cardinal Health Inc. – Business segments
- Exhibit 123: Cardinal Health Inc. – Key news
- Exhibit 124: Cardinal Health Inc. – Key offerings
- Exhibit 125: Cardinal Health Inc. – Segment focus
- 12.7 Connecticut Hypodermics Inc.
- Exhibit 126: Connecticut Hypodermics Inc. – Overview
- Exhibit 127: Connecticut Hypodermics Inc. – Product / Service
- Exhibit 128: Connecticut Hypodermics Inc. – Key offerings
- 12.8 DeRoyal Industries Inc.
- Exhibit 129: DeRoyal Industries Inc. – Overview
- Exhibit 130: DeRoyal Industries Inc. – Product / Service
- Exhibit 131: DeRoyal Industries Inc. – Key offerings
- 12.9 EXELINT International Co.
- Exhibit 132: EXELINT International Co. – Overview
- Exhibit 133: EXELINT International Co. – Product / Service
- Exhibit 134: EXELINT International Co. – Key offerings
- 12.10 Hamilton Bonaduz AG
- Exhibit 135: Hamilton Bonaduz AG – Overview
- Exhibit 136: Hamilton Bonaduz AG – Product / Service
- Exhibit 137: Hamilton Bonaduz AG – Key offerings
- 12.11 Hindustan Syringes and Medical Devices Ltd.
- Exhibit 138: Hindustan Syringes and Medical Devices Ltd. – Overview
- Exhibit 139: Hindustan Syringes and Medical Devices Ltd. – Product / Service
- Exhibit 140: Hindustan Syringes and Medical Devices Ltd. – Key offerings
- 12.12 Medtronic Plc
- Exhibit 141: Medtronic Plc – Overview
- Exhibit 142: Medtronic Plc – Business segments
- Exhibit 143: Medtronic Plc – Key news
- Exhibit 144: Medtronic Plc – Key offerings
- Exhibit 145: Medtronic Plc – Segment focus
- 12.13 Nipro Medical Corp.
- Exhibit 146: Nipro Medical Corp. – Overview
- Exhibit 147: Nipro Medical Corp. – Product / Service
- Exhibit 148: Nipro Medical Corp. – Key offerings
- 12.14 Novo Nordisk AS
- Exhibit 149: Novo Nordisk AS – Overview
- Exhibit 150: Novo Nordisk AS – Business segments
- Exhibit 151: Novo Nordisk AS – Key offerings
- Exhibit 152: Novo Nordisk AS – Segment focus
- 12.15 Retractable Technologies Inc.
- Exhibit 153: Retractable Technologies Inc. – Overview
- Exhibit 154: Retractable Technologies Inc. – Product / Service
- Exhibit 155: Retractable Technologies Inc. – Key offerings
- 12.16 Smiths Group Plc
- Exhibit 156: Smiths Group Plc – Overview
- Exhibit 157: Smiths Group Plc – Business segments
- Exhibit 158: Smiths Group Plc – Key news
- Exhibit 159: Smiths Group Plc – Key offerings
- Exhibit 160: Smiths Group Plc – Segment focus
- 12.17 Terumo Medical Corp.
- Exhibit 161: Terumo Medical Corp. – Overview
- Exhibit 162: Terumo Medical Corp. – Business segments
- Exhibit 163: Terumo Medical Corp. – Key offerings
- Exhibit 164: Terumo Medical Corp. – Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 165: Inclusions checklist
- Exhibit 166: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 167: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 168: Research methodology
- Exhibit 169: Validation techniques employed for market sizing
- Exhibit 170: Information sources
- 13.5 List of abbreviations
- Exhibit 171: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
Newsroom: https://newsroom.technavio.org/news/hypodermic-needlesmarket
SOURCE Technavio